Back to User profile » Dr Yingxin Pang
Papers published by Dr Yingxin Pang:
Overexpression of Nucleolin is a Potential Prognostic Marker in Endometrial Carcinoma
Lin Q, Ma X, Hu S, Li R, Wei X, Han B, Ma Y, Liu P, Pang Y
Cancer Management and Research 2021, 13:1955-1965
Published Date: 25 February 2021
Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivo
Zhang X, Lu T, Ma Y, Li R, Pang Y, Mao H, Liu P
OncoTargets and Therapy 2020, 13:5069-5082
Published Date: 8 June 2020
Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian Cancer [Corrigendum]
Luan W, Pang Y, Li R, Wei X, Jiao X, Shi J, Yu J, Mao H, Liu P
OncoTargets and Therapy 2019, 12:9793-9794
Published Date: 15 November 2019
Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian Cancer
Luan W, Pang Y, Li R, Wei X, Jiao X, Shi J, Yu J, Mao H, Liu P
OncoTargets and Therapy 2019, 12:8063-8074
Published Date: 3 October 2019
MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP
Pang Y, Mao H, Shen L, Zhao Z, Liu R, Liu P
OncoTargets and Therapy 2014, 7:587-597
Published Date: 23 April 2014